Search results for "Stroke"
Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://immattersacp.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022
DOACs show better safety, effectiveness than warfarin in patients with valvular afib
As a class, direct oral anticoagulants (DOACs) were associated with lower risk for ischemic stroke or systemic embolism and major bleeding events than warfarin, and results were consistent for apixaban and rivaroxaban.
https://immattersacp.org/weekly/archives/2021/03/30/1.htm
30 Mar 2021
SSRIs associated with remission of depression following intracerebral hemorrhage
Selective serotonin reuptake inhibitors (SSRIs) were associated with remission of depression following an intracerebral hemorrhage (ICH), but also higher risk of ICH recurrence in patients with pre-existing clinical, genetic, or neuroimaging risk factors for hemorrhagic stroke.
https://immattersacp.org/weekly/archives/2020/09/01/6.htm
1 Sep 2020
MKSAP Quiz: Involuntary urine loss with coughing
A 68-year-old woman is evaluated for involuntary urine loss that occurs with coughing, sneezing, and laughing and occasionally with physical exertion. She has no dysuria, urinary frequency, hematuria, or nocturia but does report vaginal dryness and dyspareunia. She performs pelvic floor muscle training exercises four times daily. Following a physical exam and pelvic exam, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2022/06/21/3.htm
21 Jun 2022
ARBs appear to have fewer side effects, same effectiveness compared to ACE inhibitors
Researchers used large international databases to compare outcomes among patients who initiated hypertension therapy with angiotensin-converting enzyme (ACE) inhibitors versus angiotensin receptor blockers (ARBs) and concluded that ARBs should be preferred.
https://immattersacp.org/weekly/archives/2021/08/03/2.htm
3 Aug 2021
Studies evaluate effects of tea, alcohol consumption on long-term health
Consumption of black tea was associated with lower mortality risk over about a decade, while reducing alcohol consumption from heavy levels to moderate or mild is associated with lower rates of overall and alcohol-related cancer.
https://immattersacp.org/weekly/archives/2022/08/30/1.htm
30 Aug 2022
Cardiac societies issue new joint guideline on management of heart failure
The updated guideline recommends sodium-glucose cotransporter-2 inhibitors for many heart failure patients, regardless of their diabetes status, among other changes.
https://immattersacp.org/weekly/archives/2022/04/05/2.htm
5 Apr 2022
NOACs linked to lower rates of diabetes complications than warfarin in patients with afib and diabetes
A retrospective study from Taiwan found that patients who received non-vitamin K antagonist oral anticoagulants (NOACs) developed fewer macrovascular and microvascular complications, had fewer glycemic emergencies, and were less likely to die than those who received warfarin.
https://immattersacp.org/weekly/archives/2022/02/15/2.htm
15 Feb 2022
PDE5 inhibitors didn't increase cardiovascular events in men on nitrates for heart disease
A Danish study also found that more men with ischemic heart disease are taking both nitrates and a phosphodiesterase type 5 (PDE5) inhibitor, with the prescription rate increasing 20-fold from 2000 to 2018.
https://immattersacp.org/weekly/archives/2022/04/19/1.htm
19 Apr 2022
Apixaban may be safer, more effective than rivaroxaban for afib
Patients taking rivaroxaban had higher rates of stroke or systemic embolism and gastrointestinal or brain bleeding compared to those taking apixaban, according to a retrospective cohort study.
https://immattersacp.org/weekly/archives/2020/03/10/4.htm
10 Mar 2020